AU2089297A - Composition for prevention of hepatic steatosis - Google Patents

Composition for prevention of hepatic steatosis

Info

Publication number
AU2089297A
AU2089297A AU20892/97A AU2089297A AU2089297A AU 2089297 A AU2089297 A AU 2089297A AU 20892/97 A AU20892/97 A AU 20892/97A AU 2089297 A AU2089297 A AU 2089297A AU 2089297 A AU2089297 A AU 2089297A
Authority
AU
Australia
Prior art keywords
prevention
composition
hepatic steatosis
steatosis
hepatic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU20892/97A
Inventor
Naobumi Ishida
Yun K. Tam
Nuzhat Zaman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
YUN K TAM
Original Assignee
YUN K TAM
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by YUN K TAM filed Critical YUN K TAM
Publication of AU2089297A publication Critical patent/AU2089297A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
AU20892/97A 1997-03-17 1997-03-17 Composition for prevention of hepatic steatosis Abandoned AU2089297A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/CA1997/000176 WO1998041216A1 (en) 1997-03-17 1997-03-17 Composition for prevention of hepatic steatosis

Publications (1)

Publication Number Publication Date
AU2089297A true AU2089297A (en) 1998-10-12

Family

ID=4173204

Family Applications (1)

Application Number Title Priority Date Filing Date
AU20892/97A Abandoned AU2089297A (en) 1997-03-17 1997-03-17 Composition for prevention of hepatic steatosis

Country Status (4)

Country Link
JP (1) JP2001514667A (en)
AU (1) AU2089297A (en)
HK (1) HK1027508A1 (en)
WO (1) WO1998041216A1 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002009757A1 (en) * 2000-08-01 2002-02-07 Shionogi & Co., Ltd. Preventives or remedies for obesity or fatty liver
DE10057290B4 (en) * 2000-11-17 2004-01-08 Fresenius Kabi Deutschland Gmbh Enteral supplement for parenteral nutrition or partial enteral / oral nutrition for critically ill, chronically ill and malnourished
US6596762B2 (en) 2001-05-17 2003-07-22 The Regents Of The University Of Colorado Antioxidant compositions and use for treatment of hepatic steatosis and steatohepatitis
CA2546601A1 (en) 2003-11-19 2005-06-09 Metabasis Therapeutics, Inc. Novel phosphorus-containing thyromimetics
EP1898926A2 (en) 2005-05-26 2008-03-19 Metabasis Therapeutics, Inc. Thyromimetics for the treatment of fatty liver diseases
CN102164595A (en) * 2008-09-19 2011-08-24 雀巢产品技术援助有限公司 Nutritional support of the immune system during anti-cancer treatment
CA3044059A1 (en) 2016-11-21 2018-05-24 Viking Therapeutics, Inc. Method of treating glycogen storage disease
CZ201740A3 (en) * 2017-01-26 2018-08-08 Vidia spol. s r.o. Use of a preparation for peroral administration containing lignin
EA201992703A1 (en) 2017-06-05 2020-04-15 Вайкинг Терапьютикс, Инк. COMPOSITIONS FOR TREATING FIBROSIS
CA3094167A1 (en) 2018-03-22 2019-09-26 Viking Therapeutics, Inc. Crystalline forms and methods of producing crystalline forms of a compound
CN114146184A (en) * 2021-12-03 2022-03-08 成都施桂行医药科技有限责任公司 Use of cationic polymers for the preparation of medicaments

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB931921A (en) * 1960-12-22 1963-07-24 Lab Roques Therapeutic compositions intended for the treatment of any hepatic malfunctionings
US4814354A (en) * 1986-09-26 1989-03-21 Warner-Lambert Company Lipid regulating agents
GB9026648D0 (en) * 1990-12-07 1991-01-23 Efamol Holdings Nutrition
EP1362587A1 (en) * 1994-01-11 2003-11-19 Stichting Zofia Use of glutamine for treating low arginine levels in the animal or human body

Also Published As

Publication number Publication date
JP2001514667A (en) 2001-09-11
HK1027508A1 (en) 2001-01-19
WO1998041216A1 (en) 1998-09-24

Similar Documents

Publication Publication Date Title
IL136086A0 (en) New composition of matter
ZA984127B (en) New composition of matter
AU7010496A (en) Composition for sustained release of an agent
AU5641098A (en) Sealant compositions
AU5100599A (en) Egf-genistein for prevention of restenosis
AU7717498A (en) Odor reducing compositions
AU1383699A (en) Coating composition
AU6119298A (en) Emulsion composition
AU6593498A (en) Controlled release compositions
AU1592299A (en) Skin rash prevention composition
AU5335798A (en) Stomatic composition
AU8747498A (en) Food-preservative composition
AU2089297A (en) Composition for prevention of hepatic steatosis
AU7685798A (en) Compositions and methods for preventing adhesion
AU5575398A (en) Hairdye compositions
AUPP342298A0 (en) Hydraulic fastening of components
AU5032298A (en) Coating compositions
GB9507297D0 (en) New composition of matter
AU1098499A (en) Emulsifier-lipid composition
EP0914815A4 (en) Composition for external use for prevention of environmental stress
AUPO565997A0 (en) Propanolamine derivatives
AU7522898A (en) Pseudo-peptide compounds as antagonists of neurokinines
AU1063699A (en) Release compositions
AUPO371096A0 (en) Corrosion inhibiting composition
AU7702996A (en) Solid composition